POCKET FOLDER
CUSTOMER: Myogen, Inc.
PROJECT DETAILS:
Myogen’s product “Aries”, a Pulmonary Arterial Hypertension medication, was involved to two international Phase-3 studies of Ambrisentan in PAH to check for effacacy, safety, and tolerability.
support@lightspeedca.net
303-527-1222
